A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
2024

Blood Test Identifies Long COVID

Sample size: 14 publication 10 minutes Evidence: moderate

Author Information

Author(s): Missailidis Daniel, Ebrahimie Esmaeil, Dehcheshmeh Manijeh Mohammadi, Allan Claire, Sanislav Oana, Fisher Paul, Gras Stephanie, Annesley Sarah J.

Primary Institution: La Trobe University

Hypothesis

Can a blood-based mRNA signature distinguish individuals with Long COVID from those who have recovered from COVID-19?

Conclusion

The study found that specific gene expressions in blood can effectively differentiate Long COVID patients from those who have recovered.

Supporting Evidence

  • Seventy genes were identified as significantly up- or down-regulated in Long COVID samples.
  • Principal Component Analysis showed that LILRB1 and LILRB2 expression discriminated Long COVID samples from COVID recovered samples.
  • Most differentially expressed genes were downregulated in Long COVID individuals.

Takeaway

Researchers found that people with Long COVID have different gene expressions in their blood compared to those who have fully recovered, which could help in diagnosing the condition.

Methodology

RNA-Seq was used to analyze the transcriptomes of PBMCs from 7 Long COVID and 7 COVID recovered individuals.

Potential Biases

Potential biases due to small sample size and specific participant selection.

Limitations

The study is based on a small pilot cohort and requires validation in larger groups.

Participant Demographics

Participants included 7 Long COVID and 7 COVID recovered individuals, average age 41 for Long COVID and 45 for recovered, with a higher percentage of females.

Statistical Information

P-Value

FDR p = 0.005 for LILRB1

Statistical Significance

pFDR < 0.05

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1450853

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication